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Abstract
Background:  Yeasts provide attractive expression platforms in combining ease of genetic
manipulation and fermentation of a microbial organism with the capability to secrete and to modify
proteins according to a general eukaryotic scheme. However, early restriction to a single yeast
platform can result in costly and time-consuming failures. It is therefore advisable to assess several
selected systems in parallel for the capability to produce a particular protein in desired amounts
and quality. A suitable vector must contain a targeting sequence, a promoter element and a
selection marker that function in all selected organisms. These criteria are fulfilled by a wide-range
integrative yeast expression vector (CoMed™) system based on A. adeninivorans- and H.
polymorpha-derived elements that can be introduced in a modular way.
Results: The vector system and a selection of modular elements for vector design are presented.
Individual single vector constructs were used to transform a range of yeast species. Various
successful examples are described. A vector with a combination of an rDNA sequence for genomic
targeting, the E. coli-derived hph gene for selection and the A. adeninivorans-derived TEF1 promoter
for expression control of a GFP (green fluorescent protein) gene was employed in a first example
to transform eight different species including Hansenula polymorpha, Arxula adeninivorans and others.
In a second example, a vector for the secretion of IL-6 was constructed, now using an A.
adeninivorans-derived LEU2 gene for selection of recombinants in a range of auxotrophic hosts. In
this example, differences in precursor processing were observed: only in A. adeninivorans processing
of a MFα1/IL-6 fusion was performed in a faithful way.
Conclusion: rDNA targeting provides a tool to co-integrate up to 3 different expression plasmids
by a single transformation step. Thus, a versatile system is at hand that allows a comparative
assessment of newly introduced metabolic pathways in several organisms or a comparative co-
expression of bottleneck genes in cases where production or secretion of a certain product is
impaired.
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Background
The exploitation of recombinant DNA technology to engi-
neer expression systems for heterologous protein produc-
tion provided a major task during the last decades.
Production procedures had to be developed that employ
platforms which meet both the demand for efficient mass
production and criteria of safety and authenticity of the
produced compounds [1,2]. In this respect, yeasts offer
considerable advantages over alternative microbial and
eukaryotic cellular systems in providing low-cost screen-
ing and production systems for authentically processed
and modified compounds. These organisms furthermore
meet safety prerequisites in that they do not harbour pyro-
gens, pathogens or viral inclusions.
The initial yeast system developed for heterologous gene
expression was based on the baker's yeast Saccharomyces
cerevisiae. This platform has been successfully applied to
the production of various FDA-approved pharmaceuticals
including insulin [3] and HBsAg [4]. However, when
using this system, certain limitations and drawbacks are
often encountered, since S. cerevisiae tends to hyperglyco-
sylate recombinant proteins; N-linked carbohydrate
chains are terminated by mannose attached to the chain
via an α1,3 bond, which is considered to be allergenic.
Other restrictions are the consequence of the limited vari-
ety of carbon sources that can be utilised by this species,
which limits the fermentation design options. Sometimes,
the preferential use of episomal vectors leads to instabili-
ties of recombinant strains; as a result, batch inconsisten-
cies of production runs can be of major concern [2].
Therefore, alternative yeast systems have been defined
that can potentially overcome the described limitations of
the traditional baker's yeast. Examples include the two
methylotrophic yeast species Hansenula polymorpha [5,6]
and Pichia pastoris [5,7], the dimorphic organism Arxula
adeninivorans [8,9] and others. These organisms share the
capability to utilize a broad range of carbon sources, two
of them (H. polymorpha and A. adeninivorans) can assimi-
late nitrate and are thermotolerant species, with the latter
exhibiting a temperature-dependent dimorphism with
hyphae formed at elevated temperature and alterations in
the extent of O glycosylation. For all systems, a range of
host strains and relevant genetic elements are available.
In case of the two methylotrophic species, engineered
strains have been developed that exhibit human-like N-
glycosylation patterns [6,7,10,11]. The genome of both
species has been completely deciphered [6,7,12], and for
H. polymorpha a microarray chip is available [13]. In case
of dimorphic A. adeninivorans species, data on chromo-
somes and on a partial characterization of the genomes
are already available [9]. A more detailed description of
some of the platforms can be found in [14] and in a recent
book on production of recombinant proteins and various
chapters therein [1,2,6,7,9,15].
Despite the superior characteristics of yeast hosts in vari-
ous developments, there is clearly no single system that is
optimal for production of all possible proteins. Predic-
tions of a successful development for a given protein can
only be made to a certain extent when restricting the ini-
tial strain engineering to a single species. The availability
of a wide-range yeast vector system enables the assessment
of several yeasts in parallel for their capability to produce
a particular protein in desired amounts and quality [16-
18]. Examples for the application of such vectors are pro-
vided in the following overview.
Results and discussion
1. Design and optimization of the CoMed™ vector system
Since vector systems of different yeast species are based on
different basic vectors it is very difficult to exchange single
cassettes between the yeast systems. To reduce this disad-
vantage the CoMed™ vector system was established con-
taining the pCoMed™ basic vector for integration of ARS,
selection markers, rDNA sequences and expression cas-
settes. For this purpose, the single modules are flanked by
identical restriction sites and are integrated in the same
location of the basic vector. In this system, various mod-
ules can be integrated. A selection of rDNA elements
derived from the A. adeninivorans or H. polymorpha clusters
has been assessed for suitability as targeting sequences.
Particular elements of both clusters derived from an ETS-
18S – 5.8S segment were found to be optimal. Due to high
conservation of the included coding regions targeting of
all yeast species is feasible [19]. If for instance the combi-
nation of rDNA and the ALEU2 gene is chosen, a range of
yeasts with this auxotrophy can be targeted. The same
holds for the insertion of a dominant selection marker
like the E.coli-derived hph gene conferring resistance to
hygromycin B in all yeast species tested so far. The expres-
sion cassette is inserted in a final step as fragments derived
from pre-constructed plasmids. A range of such cassette
elements exists harbouring a promoter of choice, among
others the A. adeninivorans-derived TEF1 promoter men-
tioned before, and a S. cerevisiae PHO5 terminator sepa-
rated by a multiple cloning site. Again, this promoter was
found to be functional in all yeast species tested so far
[20,21]. A selection of ARS sequences is available that will
result in either episomal (S. cerevisiae) or chromosomally
integrated plasmids (Hansenula polymorpha). However
inclusion of such a sequence may reduce the range of
addressible hosts.
By easy exchange of modules, such a vector can be con-
verted into a plasmid that is optimal for an individual
platform, for instance by inserting an expression cassette
with a MOX promoter element that elicits efficient geneMicrobial Cell Factories 2006, 5:33 http://www.microbialcellfactories.com/content/5/1/33
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expression in methylotrophic yeasts only. The general
design of the plasmid CoMed™ with a selection of compo-
nents is provided in Fig. 1 and Tab. 1, additional elements
and a range of available host strains based on different
species can be found in [14]. Variants of this basic vector
for the production of antibodies and derivatives thereof
are under development. In yet another design, it is possi-
ble to linearize the plasmids in a way that leaves behind
all bacterial DNA sequences.
2. Wide-range application of the CoMed™ vector system
In a first set of examples, we present the generation of
recombinants based on a range of yeast species applying a
single vector to transformation. In a first construct, a com-
bination of elements was used that is suited to transform
all yeast species tested so far, an rDNA-sequence for wide-
range targeting and the E.coli-derived hph gene as domi-
nant selection marker.
For proof of concept, an expression cassette was designed
harbouring the Aequorea victoria-derived  GFP  gene
inserted between the A. adeninivorans-derived TEF1 pro-
moter and the PHO5 terminator of S. cerevisiae [18]. An
arbitrary selection of yeast species was transformed by the
vector linearized within the rDNA targeting sequence,
namely S. cerevisiae, A. adeninivorans (budding cells and
filamentous cells), H. polymorpha, Pichia pastoris, Debaryo-
myces polymorphus and D. hansenii. In all transformants,
the heterologous DNA was observed to be mitotically sta-
ble integrated into the genome of the respective host. For
GFP production, the transformants were cultured for 48 h
in YEPD medium at 30°C and the produced GFP was
detected by fluorescence microscopy. All transformants
efficiently produced GFP as shown in Fig. 2. The GFP was
distributed within the cytosol and excluded from the vac-
uoles.
In a second construct, we combined an rDNA targeting
sequence and an A. adeninivorans-derived LEU2 [20] for
selection. For comparative production, the cytokine IL-6,
a secreted protein of industrial relevance, was selected.
Recombinant expression systems for IL-6 have been estab-
lished among others based on E. coli [38] and S. cerevisiae
[39], in addition attempts have been described for H. pol-
ymorpha [40,41]. In both systems, production is hampered
by N-terminal truncation of the product, elicited by a thiol
protease that cleaves the mature protein at Arg8 (Arg9 in
E. coli) [42]. For assessment, we inserted an expression
cassette harbouring an ORF for a MFα1/IL-6 fusion pro-
tein under control of the elements described before and
transformed leu2 auxotrophic strains of A. adeninivorans,
H. polymorpha and S. cerevisiae. Again, mitotically stable
strains were generated. Representatives of the three
derived strain collections efficiently secreted the recom-
binant cytokine into the medium. In this case, product
differences could be observed when comparing the secre-
tion products of the different yeast species: the H. polymor-
pha and S. cerevisiae-derived molecules were found to be
of smaller size than that secreted from the A. adeninivorans
host. A more detailed comparative MS analysis of tryptic
peptides revealed an N-terminal truncation at position
Arg8 in H. polymorpha and S. cerevisiae, but a correctly
processed mature IL-6 in A. adeninivorans (Fig. 3). This is
probably due to the lack of a thiol protease in this dimor-
phic species. The result emphasizes the need of a careful
early pre-selection of a platform for the development of a
production process. A detailed description of comparative
IL-6 production will be provided elsewhere.
3. Wide-range co-integration of different plasmids
It is possible to co-integrate multiple plasmids carrying
expressible heterologous genes in the ribosomal DNA by
a single transformation step [20,43]. Again, using appro-
priate selection markers and a functional wide-range pro-
Table 1: ARS, rDNA regions, selection markers and promoter 
elements of the CoMed™ vector system.
region/gene donor organism reference
ARS
■  2 µm DNA S. cerevisiae [22]
■  ARS1 S. cerevisiae [23]
■  HARS H. polymorpha [6]
■  SwARS Schw. occidentalis [24]
rDNA region
■  NTS2-ETS-18SrDNA-ITS1 H. polymorpha [7]
■  25S rDNA A. adeninivorans [25]
■  18S rDNA A. adeninivorans [19]
■  ITS-5S-ETS-18S-ITS-5,8S-ITS A. adeninivorans [19]
■  NTS2-ETS-18SrDNA-ITS1 A. adeninivorans [19]
selection marker
■  URA3 S. cerevisiae [26]
■  LEU2 S. cerevisiae [27]
■  ALEU2m A. adeninivorans [20]
■  ATRP1m A. adeninivorans [29]
■  HIS4 P. pastoris [28]
expression cassette (promoter)
■  FMD promoter H. polymorpha [5]
■  MOX promoter H. polymorpha [5]
■  TPS1 promoter H. polymorpha [30]
■  AOX1 promoter P. pastoris [31]
■  TEF1 promoter A. adeninivorans [32]
■  AHSB4m promoter A. adeninivorans [21]
■  GAA promoter A. adeninivorans [33]
■  ALIP promoter A. adeninivorans [34]
■  AINV promoter A. adeninivorans [35]
■  AXDH promoter A. adeninivorans [36]
■  RPS7 promoter Y. lipolytica [37]Microbial Cell Factories 2006, 5:33 http://www.microbialcellfactories.com/content/5/1/33
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moter for expression control, a comparative single-step
integration in a range of selected yeast platforms becomes
feasible. In the following section, three promising exam-
ples are described.
3.1 Simultaneous introduction of a new metabolic pathway into 
different yeasts
In a first example, a new metabolic pathway was intro-
duced into three different yeasts, namely D. polymorphus,
D. hansenii and  A. adeninivorans. For construction of
recombinant biocatalysts, vectors were equipped with the
genes phbA, phbB and phbC of the polyhydroxyalkanoate
(PHA) biosynthetic pathway of Ralstonia eutropha encod-
ing  β-ketothiolase, NADPH-linked acetoacetyl-CoA
reductase and PHA synthase under control of the A. aden-
inivorans-derived TEF1 promoter. Following the previous
examples, the vectors were further equipped with an
rDNA sequence and the E. coli-derived hph gene for wide-
range integration and selection. Representatives of the
three resulting strain collections were found to contain all
three heterologous genes as single copies mitotically sta-
ble integrated into the genome. In fed-batch cultivations
in minimal medium supplemented with 1% ethanol as
carbon source, the recombinant yeasts were able to con-
vert efficiently the substrates acetyl-CoA and propionyl-
CoA to PHA (2.2% of dry weight) [[9,44]- Fig. 4].
3.2 Construction of an estrogen sensor based on recombinant A. 
adeninivorans cells
Recently, a novel estrogen biosensor based on recom-
binant A. adeninivorans cells has been developed. For this
purpose, recombinant A. adeninivorans strains were engi-
neered co-expressing the human estrogen receptor
α(hERα) and a Klebsiella-derived phytase (phyK) reporter
gene under control of an A. adeninivorans-derived glu-
coamylase (GAA) promoter modified by insertion of
Design and functionality of CoMed™ vector system Figure 1
Design and functionality of CoMed™ vector system. The CoMed™ basic vector contains all E. coli elements for propagation in 
the E. coli system and a MCS for integration of ARS, rDNA, selection marker and expression cassette modules. For this pur-
pose, ARS fragments are flanked by SacII and BcuI restriction sites, rDNA regions by BcuI and Eco47III restriction sites, selection 
markers by Eco47III and SalI restriction sites and promoter elements by SalI and ApaI restriction sites [38]).
ARS
rDNA
expression
cassette
selection
marker
pBS-Basisvektor
2996 bp
Amp(r)
f1(-) origin
ColE1 ori
ApaI
SalI
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(A) Physical map of the expression/integration vector pAL-HPH-TEF-GFP used in this study Figure 2
(A) Physical map of the expression/integration vector pAL-HPH-TEF-GFP used in this study. The vector contains the 25S 
rDNA sequence of A. adeninivorans (rDNA, white box) and an expression cassette for the E. coli-derived hph gene as selection 
marker in the order A. adeninivorans-derived TEF1 promoter (TEF1 pro,grey segment), the hph-coding sequence (HPH, grey 
segment), S. cerevisiae-derived PHO5 terminator (PHO5 ter, black bar). The vector further contains a second expression cas-
sette with TEF1 promoter – GFP ORF – PHO5 terminator elements. The vector contains further an unique BglII site within the 
rDNA sequence for linearization. (B) Detection of recombinant GFP-producing yeast cells by fluorescence microscopy. Trans-
formants were cultured for 48 h in YEPD medium at 30°C and subsequently used for fluorescence analysis. (I) transmission, (II) 
GFP-fluorescence.
D. polymorphus H120
D. hansenii H158 A. adeninivorans 135
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B
II IMicrobial Cell Factories 2006, 5:33 http://www.microbialcellfactories.com/content/5/1/33
Page 6 of 13
(page number not for citation purposes)
estrogen-responsive elements (EREs). In response to the
presence of estrogenic compounds, hERα dimerizes, and
subsequently, reporter gene expression is induced by
binding of the newly generated hERα-dimer/estrogen
complex to estrogen-responsive elements (ERE) within
the promoter. The insertion of different numbers of EREs
in three alternative promoter positions and its effect on
reporter gene expression were assessed. In a particular
construct, a detection limit of 5 ng l-1 and a quantification
limit of 10 ng l-1 for 17β-estradiol-like activity could be
achieved. A convenient photometric assay enables estro-
gen monitoring in sewage samples within 30 hrs ([45] –
Fig. 5). As the two final plasmids are designed for wide-
range transformation a range of other yeast species can
now be assessed for this application.
3.3 Assessment of secretory pathway genes for the production of 
IFNγ
IFNγ is produced by CD4 and CD8-positive T and NK
(natural killer) cells. The mature protein consists of 146
amino acids. IFNγ is a potent anti-viral and anti-parasitic
agent. It has been assessed for treatment of opportunistic
infections in AIDS patients, for treatment of eosinophilia
in severe atopic dermatitis and for treatment of osteopet-
rosis [46,47]. Two active forms of 25 and 20 kDa exist, dif-
fering in the extent of glycosylation. Glycosylation is not
(A) Physical map of the expression/integration vector pAL-ALEU2m-TEF-MATalpha-IL6 used in this study Figure 3
(A) Physical map of the expression/integration vector pAL-ALEU2m-TEF-MATalpha-IL6 used in this study. The vector contains 
the 25S rDNA sequence of A. adeninivorans (rDNA, white box), the selection marker ALEU2m (grey segment) and an expres-
sion cassette for the IL6 gene in the order A. adeninivorans-derived TEF1 promoter (TEF1 pro, grey segment), the IL6-coding 
sequence, S. cerevisiae-derived PHO5 terminator(PHO5 ter, black bar) as selection marker. The vector contains a unique NcoI 
site for linearization within the rDNA sequence. (B) IL6 accumulation in recombinant S. cerevisiae, A. adeninivorans budding cell 
and mycelia cultures as well as in H. polymorpha. The strains were cultured in YMM supplemented with 2% glucose for 72 h at 
30°C (S. cerevisiae, A. adeninivorans budding cells, H. polymorpha) or 45°C (A. adeninivorans mycelia). 20 µl aliquots of culture 
media were separated on (11%) SDS-PAGE gels, transferred to nitrocellulose filters and probed with anti-IL-6 antibodies. The 
concentration of recombinant IL-6 was calculated from the signal intensity of a IL-6 standard. (1) IL-6 standard (E. coli), (2) A. 
adeninivorans G1211/pAL-ALEU2m-TEF-MATα-IL6 – budding cells (205 mg l-1), (3) A. adeninivorans G1211/pAL-ALEU2m-TEF-
MATα-IL6 – mycelia (144 mg l-1), (4) S. cerevisiae SEY6210/pAL-ALEU2m-TEF-MATα-IL6 (95 mg l-1), (5) H. polymorpha HP102/
pAL-ALEU2m-TEF-MATα-IL6 (90 mg l-1). (C) N-terminus of IL-6 secreted from recombinant S. cerevisiae, A. adeninivorans (bud-
ding cell and mycelial cultures) and from H. polymorpha strains.
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Transformation procedure based on simultaneous integration of the plasmids pAL-HPH-phbA-phbB and pAL-ALEU2m-phbC  into the 25S rDNA of A. adeninivorans G1211 (aleu2) Figure 4
Transformation procedure based on simultaneous integration of the plasmids pAL-HPH-phbA-phbB and pAL-ALEU2m-phbC 
into the 25S rDNA of A. adeninivorans G1211 (aleu2). The two plasmids pAL-HPH-phbA-phbB and pAL-ALEU2m-phbC con-
taining the expression cassettes with phbA, phbB and phbC genes are linearised by BglII or Esp3I digestion, respectively. The 
resulting fragments flanked by 25S rDNA sequences are co-integrated into the 25S rDNA by homologous recombination. 
Transformants are selected either by resistance to hygromycin B (plasmid pAL-HPH-phbA-phbB [25,44]) or the complementa-
tion of the aleu2 mutation (plasmid pAL-ALEU2m-phbC [20]).
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Principle of A. adeninivorans yeast estrogen sensor (A-YES) Figure 5
Principle of A. adeninivorans yeast estrogen sensor (A-YES). A. adeninivorans G1211 transformed with the plasmids pAL-HPH-
hERα and pAL-ALEU2m-GAA(2xERE-107)-phyK (G1211/pAL-HPH-hERα – pAL-ALEU2m-GAA(2xERE-107)-phyK) was the 
bio component of the A-YES. It expresses the estrogen receptor gene (TEF1 promoter – hERα gene – PHO5-terminator) con-
stitutively and produces a relatively constant level of recombinant hERα independent of the estrogen concentration. In the 
presence of estrogen or estrogen analogues, however, hERα forms a hERα-estrogen-dimer complex, which binds to the ERE-
region of the GAA promoter located in the second reporter gene expression cassette. The cassette (GAA-ERE- promoter – phyK 
gene – PHO5 terminator) is activated, the phyK gene is expressed and phytase is synthesized. Since this enzyme contains a 
native signal sequence it is secreted and accumulates extracellularly. The recombinant phytase level is then quantified using a 
simple biochemical method.(C) Specificity of the A-YES based on A. adeninivorans G1211/pAL-HPH-hERα – pAL-ALEU2m-
GAA(2xERE-107)-phyK for a range of steroids and steroid metabolites. The graphs depict the log concentration of 17α-ethy-
nylestradiol (), 17β-estradiol (■ ), estrone (▲ ), estriol (● ), coumestrol (❍ ) and bisphenol A (+) plotted against the recom-
binant phytase activity of the medium after 30 h incubation.
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required for biological activity [48] but for proteolytic sta-
bility [49]. It is therefore desirable to have access to an effi-
cient expression platform in which a cytokine can be
produced as glycosylated protein. The protein has been
produced in E. coli [50,51] and in mammalian cells [52].
IFNγ is poorly secreted from recombinant H. polymorpha
cells in the form of hyperglycosylated molecules. In other
examples, overexpression of secretory pathway genes has
been shown to improve both, the yield and the quality of
a recombinant product in several yeast platforms. Exam-
ples include the overexpression of KAR2 [53], PDI [54],
SSO1/2  [55],  CMK2  [56] and KEX2  [57]. However, it
became apparent that the observed improvements were
restricted to a specific recombinant product development
in meeting the demands to overcome a particular limita-
tion in the respective recombinant strains. When encoun-
tering such limitations like poor secretion, impaired
processing or glycosylation, it seems advisable to assess
several candidate genes of the secretion machinery or even
combination thereof for an enhanced probability of suc-
cess. A selection of four secretory pathway genes was
assessed for possible impact on secretion improvements
in this case. For assessment, wide-range rDNA integration
vectors harbouring the H. polymorpha-derived KAR2, PDI,
SSO2 or CNE1 genes [58] were co-integrated along with
the IFNγ integration/expression vector. Overexpression of
CNE1 resulted in an increased secretion of the cytokine
predominantly consisting of molecules of distinct size.
Deglycosylation with PNGaseF resulted in a Mr reduction
of the secreted IFNγ corresponding to the removal of two
N-linked glycoside chains. Coexpression of KAR2, PDI1
and SSO2 exhibited no effect (Fig. 6). Again, co-integra-
tion into alternative yeasts is now feasible. Furthermore a
co-integration of the IFNγ gene with more than a single
secretory pathway gene can be envisaged.
Conclusion
The CoMed™ vector system is a versatile system built up in
a modular way. Modules comprise of ARS sequences,
rDNA targeting sequences and dominant or complemen-
tation selection markers. For expression cassettes, a choice
of promoters from various sources is available, separated
in the module by a MCS from an S. cerevisiae-derived
PHO5 terminator.
A combination of an rDNA integration sequence and a
suitable selection marker enables transformation of host
Glycosylation analysis of secreted IFNγ Figure 6
Glycosylation analysis of secreted IFNγ. A strain of the pMrL-IFNg/pMrL-CNE collection was cultured on a 500 ml scale. The 
proteins of the supernatant were precipitated with (NH4)2SO4. An aliquot of the precipitate was digested with PNGase F as 
described in Materials and methods. Untreated and PNGase F-treated protein samples were compared to isolates from a pre-
vious strain collection. The various samples were separated by SDS-PAGE; proteins were visualized by immunoblotting as 
described before. (1,5,9,13) IFNγ standard (E.coli), (2,6,10,14) H. polymorpha, (3,4) H. polymorpha/CoMed8-MATα-IFNγ, (7,8) H. 
polymorpha/CoMed8-MATα-IFNγ – deglycosylated, (11,12) H. polymorpha/CoMed8-MATα-IFNγ – CoMed14-CNE, (15,16) H. 
polymorpha/CoMed8-MATα-IFNγ – CoMed14-CNE – deglycosylated.
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strains derived from a wide range of yeast species. The vec-
tors can easily be transformed into traditional species-spe-
cific vectors.
A single type of plasmid or multiple types of plasmids can
simultaneously be integrated into the genome of the vari-
ous hosts.
The vector system thus provides a powerful tool to trans-
form several yeasts in parallel at an early stage of a partic-
ular process development thereby avoiding potential cost-
and time-consuming failures.
Materials and methods
Strains and media
E. coli TOP 10 [F', mcrA,  ∆(mrr-hsdRMS-mcrBC),  Φ80
∆lacZ-∆DM15,  nupG,  ∆lacX74,  deoR,  recA1,  araD139,
∆(ara,leu), 7697, galU, galK, λ-, rpsL, endA1] from Invitro-
gen, USA, served as host strain for bacterial transforma-
tion and plasmid isolation. Strain was grown in LB
medium supplemented with ampicillin (50 µg ml-1;
AppliChem, Germany) when required for selection.
The yeast strains A. adeninivorans LS3 [59], A. adeninivo-
rans 135 [32], A. adeninivorans G1211 ([aleu2 – [60]), D.
hansenii H158 (provided by the strain collection of UFZ,
Leipzig/Germany), D. polymorphus H120 (provided by the
strain collection of UFZ, Leipzig/Germany), P. pastoris
GS115 (his4  – Invitrogen/USA) and the H. polymorpha
MedHp1 (odc1 – [14]) as well as S. cerevisiae C13ABYS86
(MATα leu2 ura3 his pra1 prb1 prc1 cps – [61]) were used
as hosts. All strains were grown either under non-selective
conditions in complex medium (YEPD) or under selective
conditions in a yeast minimal medium (YMM) supple-
mented with 2% of a selected carbon source [62,63]. Cul-
tivation was performed at 30°C.
Agar plates were prepared by adding 1.6% (w/v) agar to
the media. Hygromycin B (Roche Diagnostics, Germany)
was added as 150 – 400 µg ml-1 when required for selec-
tion.
Yeast transformation
A.adeninivorans LS3, A.adeninivorans 135, A. adeninivorans
G1211, D.hansenii H158, D.polymorphus H120, H. poly-
morpha  MedHp1,  P. pastoris GS115 and S. cerevisiae
C13ABYS86 were transformed according to [25,64]. Sta-
ble transformants were obtained after a sequence of pas-
sages on selective and non-selective media. After
transformation of plasmids with the hph selection marker,
hygromycin B-resistant colonies were selected on YEPD
agar plates supplemented with 150 – 400 mg l-1 hygromy-
cin B (200 mg l-1 for A.adeninivorans LS3 and 135, 250 mg
l-1 for D.hansenii H158 and D.polymorphus H120, 400 mg
l-1 for H. polymorpha MedHp1, 150 mg l-1 for P. pastoris
GS115and S. cerevisiae C13ABYS86). Single colonies were
isolated and grown on YEPD medium and hygromycin B
at 30°C for 2 days. This step was repeated three times
before the cells were plated on non-selective YEPD agar
and grown for 3–5 days at 30°C. A single colony from
each transformant was isolated and defined as a strain.
In case of auxothrophy complementation the transform-
ants were selected on YMM agar plates lacking the respec-
tive amino acid.
Isolation and characterisation of nucleic acids
Plasmid DNA, restriction fragment isolation, labeling of
fragments and Southern transfer were carried out as previ-
ously described by [32,65].
Protein analysis
SDS-PAGE with 6 µg cell extract protein and Western blots
were performed as described by [66]. The dye binding
method of Bradford [67] was used for quantitative deter-
mination of protein concentration in cell extract with
bovine serum albumin as a standard protein. IL-6 and
IFNγ were immunologically detected by Western blot
analysis using specific anti-IL-6 or IFNγ antibodies (R&D
systems/USA) for detection. Blots were stained with West-
ern Blue Stabilized Substrate (Promega, Germany).
IFNγ samples were digested with PNGaseF (Boehringer,
Mannheim) following the instructions of the supplier.
Untreated and digested samples were separated and visu-
alized as described before.
Fluorescence microscopy
GFP expression was visualized in yeast cells by fluores-
cence microscopy (Axioskop, Zeiss Jena, Germany; excita-
tion at 470 nm and detection using the BP500–530 nm
emission filter). These conditions allowed visualization of
GFP-mediated fluorescence avoiding a significant auto-
fluorescence background. Single images (512 × 512 pix-
els) were collected using line-averaging eight times, each
for 1 s.
Measurement of yeast dry mass and PHA
PHA, detected using gas chromatography/mass spectrom-
etry, and yeast dry mass were measured as described by
[68,69].
Estrogenic activity assay
A. adeninivorans G1211 transformed with the plasmids
pAL-HPH-hERα and pAL-ALEU2m-GAA(xERE)-phyK
(G1211/pAL-HPH-hERα – pAL-ALEU2m-GAA(xERE)-
phyK) was the bio component of the assay. These cells
were cultured in YMM with 2% glucose at 30°C for 48 h
and stored as 50 µl aliquots. For detection of estrogenic
activity, 950 µl of the samples were supplemented withMicrobial Cell Factories 2006, 5:33 http://www.microbialcellfactories.com/content/5/1/33
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2% maltose (final concentration) and 50 µl of stationary
yeast cell suspension (final OD600 nm = 1) was added. The
suspension was cultured for 30 h at 30°C on a shaker.
Subsequently all samples were centrifuged for 10 min at
5000 × g to separate the cells from the cultivation
medium. The extracellularly accumulated phytase activity
was assessed through a modified method initially
described by [70,71]. Aliquots (25 µl) of the supernatant
samples were incubated with 25 µl 0.1 M sodium-citrate
(pH 3.9) containing 3.5 mM 4-nitrophenyl phosphate for
60 min at 37°C in microtitre plates. The reaction was
stopped by adding 50 µl 15% TCA. After adding of 100 µl
1 N sodium hydroxide, 4-nitrophenol was measured at
405 nm with the reader "Sunrise" from Tecan (USA) [45].
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